Transaction in Own Shares • Nov 21, 2023
Transaction in Own Shares
Open in ViewerOpens in native device viewer
21.11.2023 07:30:14 CET | Demant A/S | Inside information
Demant to resume share buy-backs
It has previously been announced that the Group may resume its share buy-backs in 2023. In line with this, Demant announces today that it has decided to resume its share buy-backs following material deleveraging during 2023 thanks to strong cash flow generation throughout the year. Also, the level of acquisitions has been lower than originally planned, as some acquisitions are now expected to close in 2024.
There are no changes to the Group's outlook for 2023, and the gearing multiple (NIBD/EBITDA) at the end of 2023 is still expected to be within the medium- to long-term target of 2.0-2.5.
| Further information: Søren Nielsen, President & CEO |
Other contacts: René Schneider, CFO |
|---|---|
| Phone +45 3917 7300 | Mathias Holten Møller, Head of Investor Relations |
| www.demant.com | Peter Pudselykke, Investor Relations Officer |
| Henrik Axel Lynge Buchter, Manager of External Communication |
Henrik Axel Lynge Buchter, External Communication Manager, Corporate Communication & Sustainability, +45 2264 9982, [email protected]
Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and knowhow help improve people's health and hear-ing. We create life-changing differences through hearing health.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.